• Independent study shows favorable long term prognosis for CP-GEP Low Risk melanoma patients

    5 days ago - By San Diego Biotechnology

    ROTTERDAM, Netherlands and SAN DIEGO, March 17, 2023 /PRNewswire/ - SkylineDx, an innovative diagnostics company, focused on research & development of molecular diagnostics for oncology and inflammatory diseases, today announced the publication of an independent...
    Read more ...